MedPath

Dextran

Generic Name
Dextran
Brand Names
Bion Tears, Colirio Ocusan, Genteal Tears, Genteal Tears Mild, Tears Naturale, Tears Renewed
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
9004-54-0
Unique Ingredient Identifier
-
Background

Dextran is a polysaccharide that differs from others in that its glucose units are joined together 1:6 glucoside links. The main chain of glucose has short branches at frequent intervals which are probably joined by 1:3 and 1:4 glucoside links. The chains can be composed of about 200,000 glucose units. Many bacteria, like Leuconostoc, can synthesize dextran from sucrose, and this activity is used commercially to obtain dextran.

Dextran 40 is a sterile, nonpyrogenic preparation of low molecular weight dextran (average mol. wt. 40,000) in 5% Dextrose Injection or 0.9% Sodium Chloride Injection. It is administered by intravenous infusion.

Dextran 75 is a complex branched glucan with an average molecular weight 75000 Daltons. It is produced from certain bacteria that with α-1,6 glycosidic linkages between glucose molecules and α-1,3 linkages between branches. When labelled with technetium Tc99m, dextran 75 is intravenously administered as an imaging agent to detect and diagnose conditions in the vascular compartment such as pericardial effusion or ventricular aneurysm.

Indication

Dextran is used as the restoration of blood mass during surgical interventions if there is hypovolemia due to trauma or dehydration. It is as well used after the presence of hemorrhage in cases of blood loss to a level inferior to 15% of the blood mass, if compatibility test cannot be completed or when blood lots need to be tested for pathogen detection. Dextran is also used for the prevention of profound postoperative venous thrombosis.

Dextran as well presents ophthalmic applications as solutions or ointments for the temporary relief of xerophthalmia or minor ocular irritations.

Associated Conditions
Blood Circulation Disorder, Capillary disorder, Dry Eyes, Ocular Irritation, Pulmonary Embolism, Pulmonary Embolism caused by procedures associated with a high incidence of thromboembolic complications, Shock, Thrombosis, Venous Thrombosis (Disorder), Venous Thrombosis caused by procedures associated with a high incidence of thromboembolic complications
Associated Therapies
Plasma Volume Replacement, Priming fluid in pump oxygenators therapy

Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study

Conditions
Type 2 Diabetes
Diabetic Nephropathies
Adolescent Obesity
Diabetic Kidney Disease
Nephropathy
Obesity
Diabetes Type 2
Interventions
Drug: Aminohippurate Sodium Inj 20%
Drug: Iohexol Inj 300 MG/ML
Drug: Dextran 40
Procedure: Renal Biopsy
Radiation: Positron Emission Tomography
First Posted Date
2022-09-07
Last Posted Date
2022-11-02
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
100
Registration Number
NCT05530356
Locations
🇺🇸

Children's Hospital Colorado, Aurora, Colorado, United States

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2022-04-06
Last Posted Date
2022-09-02
Lead Sponsor
Andover Research Eye Institute
Target Recruit Count
61
Registration Number
NCT05314621
Locations
🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

Phase 4
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2022-03-04
Last Posted Date
2022-05-03
Lead Sponsor
Andover Research Eye Institute
Target Recruit Count
58
Registration Number
NCT05265910
Locations
🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)

Recruiting
Conditions
Diabetic Kidney Disease
Adolescent Obesity
Kidney Hypoxia
Puberty
Type 2 Diabetes Mellitus
Pre Diabetes
Interventions
First Posted Date
2021-08-17
Last Posted Date
2024-04-11
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
100
Registration Number
NCT05008276
Locations
🇺🇸

Children's Hospital Colorado, Aurora, Colorado, United States

Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit

Phase 1
Completed
Conditions
Keratolysis
Interventions
Drug: Riboflavin
Drug: Dextran
Device: UVA Light Source
First Posted Date
2016-08-11
Last Posted Date
2023-05-10
Lead Sponsor
Joseph B. Ciolino, MD
Target Recruit Count
76
Registration Number
NCT02863809
Locations
🇺🇸

UC Davis Health System Eye Center, Sacramento, California, United States

🇺🇸

The Jules Stein Eye Institute, Los Angeles, California, United States

🇺🇸

Shiley Eye Institute, University of California, San Diego, San Diego, California, United States

and more 10 locations

Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
6
Registration Number
NCT00000690
Locations
🇺🇸

Johns Hopkins Hosp, Baltimore, Maryland, United States

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
60
Registration Number
NCT00001009
Locations
🇺🇸

Univ of Massachusetts Med Ctr, Worcester, Massachusetts, United States

🇺🇸

Univ of Minnesota, Minneapolis, Minnesota, United States

🇺🇸

UCLA CARE Ctr, Los Angeles, California, United States

and more 5 locations

Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
10
Registration Number
NCT00000684
Locations
🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath